Gluconate intake by engineered T1D mice did not affect body-weight gain or liver function, as assessed in terms of the serum levels of ALT and AST, over the 4-week treatment period (Supplementary Figure S13). The gene discussed is GPT; the disease is type 1 diabetes mellitus.